Oruka Therapeutics (ORKA) Prepaid Assets (2010 - 2026)
Oruka Therapeutics' (ORKA) quarterly Prepaid Assets came in at $6.4 million in Q1 2026, up 114.79% year-on-year from $3.0 million in Q1 2025, and down 5.77% quarter-over-quarter from $6.8 million in Q4 2025.
Oruka Therapeutics (ORKA) Prepaid Assets (2010 - 2026) Analysis & Trends
Oruka Therapeutics' Prepaid Assets history runs 17 years deep, the most recent figure standing at $6.4 million for Q1 2026.
- On a quarterly basis, Prepaid Assets rose 114.79% year-over-year to $6.4 million in Q1 2026; TTM through Mar 2026 was $6.4 million, a 114.79% increase from a year earlier, with the FY2025 full-year figure at $6.8 million, up 457.99% from the prior year.
- Prepaid Assets retreated to $6.4 million in Q1 2026 per ORKA's latest filing, from $6.8 million in the prior quarter.
- Across five years, Prepaid Assets topped out at $6.8 million in Q4 2025 and bottomed at $161000.0 in Q4 2023.
- The 5-year median for Prepaid Assets is $1.2 million (2022), against an average of $2.1 million.
- Across the five-year window, Prepaid Assets tumbled 76.08% in 2022 and jumped 658.39% in 2024, its largest moves.
- Year by year, Prepaid Assets stood at $254000.0 in 2022, then tumbled by 36.61% to $161000.0 in 2023, then soared by 658.39% to $1.2 million in 2024, then soared by 457.99% to $6.8 million in 2025, then dropped by 5.77% to $6.4 million in 2026.
- Per Business Quant, the three latest ORKA Prepaid Assets figures stand at $6.4 million (Q1 2026), $6.8 million (Q4 2025), and $6.0 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Oruka Therapeutics | 36.09 Mn | -795.06 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 6.42 Mn |
| Dec 31, 2025 | 6.81 Mn |
| Sep 30, 2025 | 6.01 Mn |
| Jun 30, 2025 | 3.61 Mn |
| Mar 31, 2025 | 2.99 Mn |
| Dec 31, 2024 | 1.22 Mn |
| Sep 30, 2024 | 2.07 Mn |
| Jun 30, 2024 | 537,000.00 |
| Mar 31, 2024 | 767,000.00 |
| Dec 31, 2023 | 161,000.00 |
| Sep 30, 2023 | 405,000.00 |
| Jun 30, 2023 | 599,000.00 |
| Mar 31, 2023 | 852,000.00 |
| Dec 31, 2022 | 254,000.00 |
| Sep 30, 2022 | 611,000.00 |
| Jun 30, 2022 | 1.22 Mn |
| Mar 31, 2022 | 1.48 Mn |
| Dec 31, 2021 | 1.06 Mn |
| Sep 30, 2021 | 1.35 Mn |
| Jun 30, 2021 | 1.60 Mn |